News Releases

SAN DIEGO, May 17, 2016 /PRNewswire/ -- Over 300 Attendees from the world of biosimilars are heading to San Diego this week for the World Biosimilar Congress USA 2016, hosted by Terrapinn Inc.

• Zydus Cadila will be showcasing their strategy to enter the US market
• Steve Miller, Chief Medical Officer of Express Scripts will be explaining how to design a clinical trial for the proper status through a PBM
• The event is co-located with the Americas Antibody Congress and the Cell Culture World Congress – your ticket gets you in to all three!

BOOK your ticket now at http://goo.gl/Ll9aCu

They will be joined by hundreds of other attendees from a wide range of biopharma and biotech, including:

Amunix, XL-protein, Janssen, Novartis, GSK, Bristol-Meyers Squibb, Bio-Techne, Bioinformatics Inc., Aldevron, Trellis Biosciences, Merck & Co., Immunogen, Genentech, Curemeta, Valerion, MabVax, Regeneron, XBiotech, Mapp Pharmaceuticals, Visterra, MedImmune, Takeda, Tetralogic, Global Biological Standard Institute, NIH, Arsanis, Express Scripts, Novation/Vizient, Pfenex, Boehringer Ingelheim, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Harvest Moon Pharmaceuticals, Merck Serono, Biocon, Protein Sciences Corporation, Pfizer, Zydus Cadila, Biogen

Don't miss out – tickets will run out soon. BOOK your ticket now at http://goo.gl/Ll9aCu

See you in San Diego!
BOOK your ticket now at http://goo.gl/Ll9aCu

SOURCE Terrapinn Inc.